Retinal Vein Occlusion  >>  triamcinolone acetonide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triamcinolone acetonide / Generic mfg.
BRVO, NCT01044329: Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion

Unknown status
2
90
RoW
Bevacizumab, Triamcinolone Acetonide
Shahid Beheshti University of Medical Sciences, Labbafinejad Medical Center
Branch Retinal Vein Occlusion
08/10
12/10
NCT01178697: Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)

Unknown status
2
RoW
Bevasizumab, Triamcinolone Acetonide
Shahid Beheshti University of Medical Sciences, Ophthalmic Research Center
Central Retinal Vein Occlusion
09/10
12/10

Download Options